Long QT syndrome: an emerging role for inflammation and immunity

The Long QT Syndrome (LQTS), classified as congenital or acquired, is a multi-factorial disorder of myocardial repolarization predisposing to life-threatening ventricular arrhythmias, particularly torsades de pointes. In the latest years inflammation and immunity have been increasingly recognized as...

Full description

Bibliographic Details
Main Authors: Pietro Enea eLazzerini, Pier Leopoldo eCapecchi, Franco eLaghi-Pasini
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fcvm.2015.00026/full
_version_ 1811294471730495488
author Pietro Enea eLazzerini
Pier Leopoldo eCapecchi
Franco eLaghi-Pasini
author_facet Pietro Enea eLazzerini
Pier Leopoldo eCapecchi
Franco eLaghi-Pasini
author_sort Pietro Enea eLazzerini
collection DOAJ
description The Long QT Syndrome (LQTS), classified as congenital or acquired, is a multi-factorial disorder of myocardial repolarization predisposing to life-threatening ventricular arrhythmias, particularly torsades de pointes. In the latest years inflammation and immunity have been increasingly recognized as novel factors crucially involved in modulating ventricular repolarization. In the present paper we critically review the available information on this topic, also analyzing putative mechanisms and potential interplays with the other etiologic factors, either acquired and inherited.Accumulating data indicate inflammatory activation as a potential cause of acquired LQTS. The putative underlying mechanisms are complex but essentially cytokine-mediated, including both direct actions on cardiomyocyte ion channels expression and function, and indirect effects resulting from an increased central nervous system sympathetic drive on the heart. Autoimmunity represents another recently arising cause of acquired LQTS. Indeed, increasing evidence demonstrates that autoantibodies may affect myocardial electric properties by directly cross-reacting with the cardiomyocyte and interfering with specific ion currents as a result of molecular mimicry mechanisms. Intriguingly, recent data suggest that inflammation and immunity may be also involved in modulating the clinical expression of congenital forms of LQTS, possibly triggering or enhancing electrical instability in patients who already are genetically predisposed to arrhythmias. In this view, targeting immuno-inflammatory pathways may in the future represent an attractive therapeutic approach in a number of LQTS patients, thus opening new exciting avenues in antiarrhythmic therapy.
first_indexed 2024-04-13T05:18:03Z
format Article
id doaj.art-0489e79160164298bf084900bba041d7
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-13T05:18:03Z
publishDate 2015-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-0489e79160164298bf084900bba041d72022-12-22T03:00:50ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2015-05-01210.3389/fcvm.2015.00026137646Long QT syndrome: an emerging role for inflammation and immunityPietro Enea eLazzerini0Pier Leopoldo eCapecchi1Franco eLaghi-Pasini2University of Siena, SienaUniversity of Siena, SienaUniversity of Siena, SienaThe Long QT Syndrome (LQTS), classified as congenital or acquired, is a multi-factorial disorder of myocardial repolarization predisposing to life-threatening ventricular arrhythmias, particularly torsades de pointes. In the latest years inflammation and immunity have been increasingly recognized as novel factors crucially involved in modulating ventricular repolarization. In the present paper we critically review the available information on this topic, also analyzing putative mechanisms and potential interplays with the other etiologic factors, either acquired and inherited.Accumulating data indicate inflammatory activation as a potential cause of acquired LQTS. The putative underlying mechanisms are complex but essentially cytokine-mediated, including both direct actions on cardiomyocyte ion channels expression and function, and indirect effects resulting from an increased central nervous system sympathetic drive on the heart. Autoimmunity represents another recently arising cause of acquired LQTS. Indeed, increasing evidence demonstrates that autoantibodies may affect myocardial electric properties by directly cross-reacting with the cardiomyocyte and interfering with specific ion currents as a result of molecular mimicry mechanisms. Intriguingly, recent data suggest that inflammation and immunity may be also involved in modulating the clinical expression of congenital forms of LQTS, possibly triggering or enhancing electrical instability in patients who already are genetically predisposed to arrhythmias. In this view, targeting immuno-inflammatory pathways may in the future represent an attractive therapeutic approach in a number of LQTS patients, thus opening new exciting avenues in antiarrhythmic therapy.http://journal.frontiersin.org/Journal/10.3389/fcvm.2015.00026/fullAutoantibodiesCytokinesImmunityInflammationLong QT SyndromeAnti-Ro/SSA
spellingShingle Pietro Enea eLazzerini
Pier Leopoldo eCapecchi
Franco eLaghi-Pasini
Long QT syndrome: an emerging role for inflammation and immunity
Frontiers in Cardiovascular Medicine
Autoantibodies
Cytokines
Immunity
Inflammation
Long QT Syndrome
Anti-Ro/SSA
title Long QT syndrome: an emerging role for inflammation and immunity
title_full Long QT syndrome: an emerging role for inflammation and immunity
title_fullStr Long QT syndrome: an emerging role for inflammation and immunity
title_full_unstemmed Long QT syndrome: an emerging role for inflammation and immunity
title_short Long QT syndrome: an emerging role for inflammation and immunity
title_sort long qt syndrome an emerging role for inflammation and immunity
topic Autoantibodies
Cytokines
Immunity
Inflammation
Long QT Syndrome
Anti-Ro/SSA
url http://journal.frontiersin.org/Journal/10.3389/fcvm.2015.00026/full
work_keys_str_mv AT pietroeneaelazzerini longqtsyndromeanemergingroleforinflammationandimmunity
AT pierleopoldoecapecchi longqtsyndromeanemergingroleforinflammationandimmunity
AT francoelaghipasini longqtsyndromeanemergingroleforinflammationandimmunity